The Intelligence from The Economist cover image

A hardline act to follow: Iran’s presidential election

The Intelligence from The Economist

00:00

Advancements in COVID-19 Antibody Therapy

This chapter discusses the recent breakthroughs in COVID-19 treatments, particularly focusing on the effectiveness of monoclonal antibodies in enhancing patient survival rates. It highlights a significant study that offers renewed hope for critically ill patients lacking adequate antibody production.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner